Concurrence of polyostotic fibrous dysplasia and spinal aspergillus in non-immunocompromised adult patient:case report

• DOI: 10.5455/jtomc.2017.05.071
• Publication Date: 2017-11-15T18:50:31Z
• Authors: Ramazan Pasahan; Mehmet Durak; Mehmet Aladag; Ayşe Akatli; Ismail Yildirim
• Keywords: Polyostotic fibrous dysplasia; Concurrence

Aspergillus, a rare agent in spinal infections, is often transmitted via inhalation. It can be traced as an infectious immunocompromised patients. While non-immunocompromised patients, it highly unlikely to cause spondylodiscitis. Radiological findings remind tuberculosis. The recommended medical treatment applied with Itraconazole and Amphotericin B. Surgical indication involves the presence of progressive neurological deficit, instability biopsy requirement. Fibrous dysplasia was first reported 1938 by Lichtenstein benign developmental disorder skeletal system with uncertain etiology. Polyostotic type involved more than one bone, while monostotic occurs involving only bone structure. Spinal involvement may lead collapse fractures deformity development most common complaint pain. In our case, these two disorders occur concurrently, causing bone destruction severe pain, no similar cases were found in the literature.